Jin Chan Peng

Dr. Jin Chan Peng

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 May 2025 in Medicine
Verified
Journal Article
Open access
LLLiqun Li
Liqun Li
LLLijian Liu
Lijian Liu
JXJieru Mm Xie
Jieru Mm Xie
JPJin Chan Peng
Jin Chan Peng
GCGuangwen Mm Chen
Guangwen Mm Chen
XSXie Sheng
Xie Sheng
The associations between specific inflammatory cytokines and gastroesophageal reflux disease (GERD) have been confirmed, while their causal relationships remain unclear. We conducted a bidirectional 2-sample Mendelian randomization analysis (MRA) to reveal the causal correlations between 91 inflammatory factors and GERD, thereby conducting a 2-step MRA analysis to reveal the mediating function of 1400 metabolites therein. Data related to 91 inflammatory cytokines were derived from Genome-Wide Association Studies (GWAS) data with 14,824 samples. GWAS data about GERD were obtained from a large genome research project in Finland, including 28,859 GERD cases and 3,50,064 controls. GWAS data about 1400 circulating metabolites were derived from a cohort of 8299 individuals. The inverse variance weighted approach was introduced to obtain the primary MRA results, complemented by 4 additional methods for supportive analyses. Additionally, the study conducted sensitivity analyses with different methods to evaluate heterogeneity and horizontal pleiotropy. Our findings indicated that higher predicted C-X-C motif chemokine 1 [OR = 1.052, 95% CI: 1.004 − 1.103, P = .035], interleukin-1-alpha [OR = 1.083, 95% CI: 1.018 − 1.152, P = .012], and interleukin-4 [IL-4, OR = 1.081, 95% CI: 1.018 − 1.147, P = .011] increased the risk of GERD; whereas tumor necrosis factor ligand superfamily member 12 [OR = 0.958, 95% CI: 0.9174–0.9999, P = .0493] decreased the risk of GERD. No significant statistical differences were found for other inflammatory cytokines. Genetic susceptibility to GERD had no impact on any traits related to circulating inflammatory cytokines. Four metabolites associated with elevated IL-4 levels were identified, including (1-enyl-oleoyl)-GPE (P-18:1), 4-methyl guaiacol sulfate, X-12730, and X-17685, but their mediating effects were not statistically significant (P > .05). This study convincingly proved the causal impact of inflammatory factors on GERD. It confirms that C-X-C motif chemokine 1, interleukin-1-alpha, and IL-4 increase the risk of GERD, while tumor necrosis factor ligand superfamily member 12 reduces it. Additionally, several circulating metabolites are associated with elevated IL-4 levels. However, the evidence for their role as potential mediators in the pathway between IL-4 and GERD risk remains insufficient. The findings of this study propel further comprehension of the pathogenesis of GERD and also point out the therapeutic potential for interventions targeting inflammatory cytokine-targeted inventions.

11 July 2025 in Medicine
Verified
Journal Article
Open access
LLLiqun Mm Li
Liqun Mm Li
LLLijian Liu
Lijian Liu
JTJinJing Tan
JinJing Tan
HPHongxia Bs Pan
Hongxia Bs Pan
CYChengning Mm Yang
Chengning Mm Yang
XSXie Sheng
Xie Sheng
Studies have proven an association between the specific antibody-mediated immune response and gastroesophageal reflux disease (GERD); however, the exact causal associations remain unclear. Our research aims to evaluate the causal relationships between the genetic susceptibility to 46 antibody-mediated immune responses and GERD, with the bidirectional two-sample Mendelian randomization (TSMR) and to explore the mediating effects of 91 circulating inflammatory cytokines by a two-step MR analysis. Multiple MR analysis methods, including inverse variance weighted, MR-Egger, weighted mode, weighted median, simple mode, and MR pleiotropy residual sum and outlier, were employed for the bidirectional TSMR analysis. Besides, sensitivity analyses, such as Cochran Q statistics, MR-Egger intercept, MR pleiotropy residual sum and outlier global test, and the leave-one-out method were implemented to identify potential heterogeneity and pleiotropy. In the forward MR analysis, the inverse variance weighted method demonstrated that anti-cytomegalovirus (anti-CMV) IgG seropositivity (OR = 1.031, 95% CI: 1.000–1.062, P = .048), levels of human herpes virus (HHV) 7 U14 antibody (OR = 1.097, 95% CI: 1.032–1.167, P = .003), and herpes simplex virus 1 (HSV-1) mgG-1 antibody (OR = 1.069, 95% CI: 1.020–1.119, P = .005), which have higher genetic prediction, are positively related to GERD risks. Reverse MR analysis revealed GERD increased the level of Epstein–Barr virus VCA p18 antibody (OR = 1.255, 95% CI: 1.028–1.533, P = .026), while decreased the anti-CMV IgG seropositivity (OR = 0.663, 95% CI: 0.444–0.991, P = .045) and HHV 7 U14 antibody level (OR = 0.777, 95% CI: 0.630–0.958, P = .018) as well. Besides, other antibodies, including anti-Helicobacter pylori (H pylori) IgG, H pylori CagA, and H pylori VacA demonstrated no correlations (neither positive nor negative) with GERD risks. Surprisingly, TSMR showed that 91 cytokines seemed not to mediate HSV-1 mgG-1 to enhance GERD risks. The research provided convincing evidence for establishing a causal relationship between antibody-mediated immune responses and GERD, proving that genetic-prediction-based HSV-1 mgG-1 could increase GERD risk and that inflammatory factors may not be involved in mediating this association. Besides, GERD was found to reduce Epstein–Barr virus VCA p18 antibody. Moreover, we revealed the bidirectional causal relationships between GERD and the antibodies, including anti-CMV IgG, HHV 7 U14. This research may contribute to a better understanding of the mechanism that triggers GERD, also emphasizing the clinical potential of therapeutic interventions targeting antibody-mediated immune responses.